## COP â€“ Intermediate risk (Group B)

**Cyclophosphamide (CPM)**
-	Route: IV 
-	Dosage: 300 mg/m2/dose in 100ml NS to infuse over 60 min (no need mesna)
-   Dilute with 0.9% NaCl to a target concentration of < 20 mg/mL, administer via IV infusion over 1 hour
-	Used on Day 1

**VinCRIStine (O)**
-	Route: IV
-	Dosage: 1 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Day 1
-	Caution: Maximum dose: 2 mg

**Prednisolone (P)**
-	Route: PO 
-	Dosage: 60mg/m2/day in 2 divided doses
-	Used in days 1 to 7 
-	Caution: You may stop Prednisolone if tumour lysis cannot be controlled


**Triple Intrathecal (TIT):**

Triple intrathecal (IT) therapy doses, according to patient age, are as follows:

-	For patients under 1 year of age, administer methotrexate 8 mg, hydrocortisone 8 mg, and cytarabine 16 mg, in a total volume of 3 mL.
-	For patients aged 1 to 2 years, administer methotrexate 10 mg, hydrocortisone 10 mg, and cytarabine 20 mg, in a total volume of 4 mL.
-	For patients aged 2 to 3 years, administer methotrexate 12 mg, hydrocortisone 12 mg, and cytarabine 24 mg, in a total volume of 5 mL.
-	For patients older than 3 years, administer methotrexate 15 mg, hydrocortisone 15 mg, and cytarabine 30 mg, in a total volume of 6 mL.
-	These doses are to be given on Day 1 only 
-	Oral Folinic acid 15 mg/m2 24 hours after TIT




